Jiang Zhang
CEO @ LongRiver Investments
Jiang Zhang is a Series B investor at LongRiver Investments focused on Biotechnology and FinTech. Jiang Zhang is the CEO at Ping An Ventures. He attended INSEAD.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Jiang Zhang invests in
Stages Jiang Zhang invests in
Countries Jiang Zhang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (67%)
- FinTech 1 (33%)
- Finance 1 (33%)
- Medical 1 (33%)
- Health Care 1 (33%)
Stage
- Series B 1 (33%)
- Series D 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- United States 2 (67%)
- Israel 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rani Therapeutics
|
Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replacesubcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage. | Venture - Series Unknown / Feb 27, 2016 | |
Ativa Medical
|
Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology.The company was founded in 2008 and headquartered in Saint Paul,Minnesota. | $15M / Series B / Sep 17, 2015 | |
eToro
|
EToro is a social trading and investment network that allows users to trade currencies, commodities, indices, crypto assets, and stocks. It is a multi-asset investment platform that empowers people to grow their knowledge and wealth as part of a global community. | $27M / Series D / Nov 26, 2014 |
Co-Investors
About LongRiver Investments
LRI Jiangyuan Investment continues to focus on the medical and technology fields.
LongRiver Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jiang Zhang
CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jiang Zhang invest in?
Jiang Zhang invests primarily in Biotechnology, FinTech and Finance startups, most often at Series B and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jiang Zhang?
Public channels for Jiang Zhang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jiang Zhang last invest?
The most recent investment recorded for Jiang Zhang closed in Feb 2016. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
